Detalles de la búsqueda
1.
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
Blood
; 143(17): 1752-1757, 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194687
2.
DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia.
Genome Res
; 31(5): 747-761, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33707228
3.
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.
Blood
; 134(8): 688-698, 2019 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292113
4.
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Blood
; 121(2): 385-91, 2013 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23160462
5.
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood
; 121(1): 159-69, 2013 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23100311
6.
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia.
Blood
; 120(12): 2466-74, 2012 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22786882
7.
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Blood
; 120(2): 249-58, 2012 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22529287
8.
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.
Nat Genet
; 37(3): 265-74, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15723065
9.
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Blood
; 118(15): 4188-98, 2011 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21828125
10.
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Blood
; 118(26): 6920-9, 2011 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22031865
11.
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(5): 788-92, 2010 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20442368
12.
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(18): 3622-6, 2010 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-20656931
13.
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(25): 5660-9, 2010 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20841507
14.
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.
Blood Cancer Discov
; 3(2): 154-169, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35247900
15.
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Haematologica
; 96(10): 1488-95, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21659357
16.
DNA methylation changes in a human cell model of breast cancer progression.
Mutat Res
; 688(1-2): 28-35, 2010 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20193695
17.
CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.
PLoS Genet
; 3(9): 1757-69, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17907813
18.
Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing.
BMC Genomics
; 8: 131, 2007 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-17524140
19.
Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations.
BMC Genomics
; 8: 446, 2007 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-18053125
20.
Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line.
Cancer Res
; 64(10): 3465-73, 2004 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15150099